Adjunctive Monoclonal Antibody Therapy for Pott's Puffy Tumor Complicating CRSwNP: A Case Report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 41133930.
- Also identified by DOI 10.1002/lary.70218.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case report describes the novel use of adjunctive mepolizumab, a monoclonal antibody, in the management of a Pott's Puffy Tumor (PPT) in a 62-year-old male with chronic rhinosinusitis with nasal polyps (CRSwNP). Following extensive surgery to establish drainage, mepolizumab was administered postoperatively to mitigate the risk of bony restenosis and polyp recurrence. Two years after the surgery, the patient showed sustained symptom relief and a patent frontal sinus drainage pathway, suggesting that this therapy may be a valuable addition for complex CRSwNP cases complicated by PPT.
Medical subject headings
- Pott Puffy Tumor
- Antibodies, Monoclonal, Humanized
- Nasal Polyps
- Sinusitis
- Rhinitis